{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-06",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "43598-625",
      "generic_name": "Phentermine and Topiramate Extended-Release",
      "labeler_name": "Dr.Reddys Laboratories Inc",
      "dea_schedule": "CIV",
      "brand_name": "Phentermine and Topiramate Extended-Release",
      "active_ingredients": [
        {
          "name": "PHENTERMINE HYDROCHLORIDE",
          "strength": "7.5 mg/1"
        },
        {
          "name": "TOPIRAMATE",
          "strength": "46 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "43598-625-30",
          "description": "30 CAPSULE in 1 BOTTLE (43598-625-30)",
          "marketing_start_date": "20250612",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Dr.Reddys Laboratories Inc"
        ],
        "rxcui": [
          "1302827",
          "1302839",
          "1302850",
          "1313059"
        ],
        "spl_set_id": [
          "260c3f90-163d-0bdd-1099-55d18a900e68"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0343598626307",
          "0343598624303",
          "0343598625300"
        ],
        "nui": [
          "N0000008486",
          "N0000185506",
          "N0000182140"
        ],
        "pharm_class_pe": [
          "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
        ],
        "pharm_class_moa": [
          "Cytochrome P450 3A4 Inducers [MoA]",
          "Cytochrome P450 2C19 Inhibitors [MoA]"
        ],
        "unii": [
          "0H73WJJ391",
          "0K2I505OTV"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "CAPSULE",
      "spl_id": "ce37425a-12f1-722f-ab5b-d95615c635a0",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20250612",
      "product_id": "43598-625_ce37425a-12f1-722f-ab5b-d95615c635a0",
      "application_number": "ANDA208175",
      "brand_name_base": "Phentermine and Topiramate Extended-Release",
      "pharm_class": [
        "Appetite Suppression [PE]",
        "Cytochrome P450 2C19 Inhibitors [MoA]",
        "Cytochrome P450 3A4 Inducers [MoA]",
        "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
        "Increased Sympathetic Activity [PE]",
        "Sympathomimetic Amine Anorectic [EPC]"
      ]
    }
  ]
}